DocGo (DCGO) Stock Forecast & Price Target

DocGo Inc. has demonstrated growth within its Transportation Services segment, achieving a year-over-year increase of 5.4% to $50.8 million, driven by new business developments. Management projects an increase in total transports to nearly 700,000 by 2026, supported by recent contracts and expansions with national health systems. Additionally, the company's payor business has successfully expanded its number of assigned lives, surpassing 900,000, reflecting a robust growth trajectory since the conclusion of the fiscal year 2024.

DocGo Inc. has reported lower than expected revenue alongside higher operational expenses, leading to adjusted EBITDA results of ($3.9 million) compared to an estimated $5.2 million, reflecting a negative margin of (4.1%). In light of these poor performance indicators, the company's FY25 adjusted EBITDA outlook has been revised down to a range of ($30 million) to ($20 million) from previous expectations of achieving a 5% margin. Additionally, the revenue guidance for FY25 has been significantly lowered to between $300 million and $330 million, down from earlier projections of $410 million to $450 million.